- Home
- KOD vs PINE Comparison
KOD vs PINE Comparison
Compare KOD & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- PINE
- Stock Information
- Founded
- KOD 2009
- PINE 2019
- Country
- KOD United States
- PINE United States
- Employees
- KOD N/A
- PINE N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- PINE Real Estate Investment Trusts
- Sector
- KOD Health Care
- PINE Real Estate
- Exchange
- KOD Nasdaq
- PINE Nasdaq
- Market Cap
- KOD 198.4M
- PINE 200.1M
- IPO Year
- KOD 2018
- PINE 2019
- Fundamental
- Price
- KOD $10.57
- PINE $14.58
- Analyst Decision
- KOD Hold
- PINE Strong Buy
- Analyst Count
- KOD 4
- PINE 5
- Target Price
- KOD $11.25
- PINE $18.30
- AVG Volume (30 Days)
- KOD 681.7K
- PINE 79.8K
- Earning Date
- KOD 08-13-2025
- PINE 07-24-2025
- Dividend Yield
- KOD N/A
- PINE 7.81%
- EPS Growth
- KOD N/A
- PINE N/A
- EPS
- KOD N/A
- PINE N/A
- Revenue
- KOD N/A
- PINE $56,340,000.00
- Revenue This Year
- KOD N/A
- PINE $13.78
- Revenue Next Year
- KOD N/A
- PINE $0.29
- P/E Ratio
- KOD N/A
- PINE N/A
- Revenue Growth
- KOD N/A
- PINE 17.14
- 52 Week Low
- KOD $1.92
- PINE $13.95
- 52 Week High
- KOD $11.60
- PINE $19.42
- Technical
- Relative Strength Index (RSI)
- KOD 77.63
- PINE 53.32
- Support Level
- KOD $7.69
- PINE $14.05
- Resistance Level
- KOD $8.45
- PINE $15.00
- Average True Range (ATR)
- KOD 0.83
- PINE 0.28
- MACD
- KOD 0.17
- PINE 0.08
- Stochastic Oscillator
- KOD 85.66
- PINE 59.62
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.